论文部分内容阅读
目的:观察华法林治疗慢性肺源性心脏病合并肺动脉高压的疗效。方法:选取我院2011年5月～2012年6月住院的慢性肺源性心脏病患者60例,分为治疗组和对照组。2组均给予以抗炎、吸氧、平喘等常规治疗,治疗组在常规治疗基础上给予华法林口服治疗。结果:治疗组显效率和总有效率分别与对照组比较,差异均有统计学意义(P<0.05)。结论:华法林降低慢性肺源性心脏病合并肺动脉高压疗效显著,值得推广。
Objective: To observe the curative effect of warfarin on chronic pulmonary heart disease with pulmonary hypertension. Methods: Sixty patients with chronic cor pulmonale who were hospitalized from May 2011 to June 2012 in our hospital were divided into treatment group and control group. Both groups were given anti-inflammatory, oxygen, asthma and other conventional treatment, the treatment group on the basis of routine treatment given warfarin oral treatment. Results: The effective rate and total effective rate in the treatment group were significantly different from those in the control group (P <0.05). CONCLUSION: Warfarin is effective in reducing chronic pulmonary heart disease complicated with pulmonary hypertension.